Icon

SCEMBLIX (nda215358)- (EQ 100MG BASE)

ASCIMINIB HYDROCHLORIDE NOVARTIS
EQ 100MG BASE
No No
2040-May-14 2026-Oct-29
None None
None No
SCEMBLIX is a kinase inhibitor indicated for the treatment of adult patients with: • Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKIs). • Ph+ CML in CP with the T315I mutation.
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 100MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.